Insider Transactions in Q1 2023 at Artivion, Inc. (AORT)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 02
2023
|
Dennis B Maier SVP, Operations |
SELL
Open market or private sale
|
Direct |
1,121
-2.15%
|
$14,573
$13.41 P/Share
|
|
Mar 02
2023
|
Rochelle L. Maney VP, Quality |
SELL
Open market or private sale
|
Direct |
821
-2.71%
|
$10,673
$13.41 P/Share
|
|
Mar 02
2023
|
Matthew A Getz VP, Human Resources |
SELL
Open market or private sale
|
Direct |
702
-1.88%
|
$9,126
$13.41 P/Share
|
|
Mar 02
2023
|
Amy Horton VP, Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
702
-0.65%
|
$9,126
$13.41 P/Share
|
|
Mar 02
2023
|
Andrew M Green VP Regulatory |
SELL
Open market or private sale
|
Direct |
825
-3.13%
|
$10,725
$13.41 P/Share
|
|
Mar 02
2023
|
James P Mackin President & CEO |
SELL
Open market or private sale
|
Direct |
9,990
-1.78%
|
$129,870
$13.41 P/Share
|
|
Mar 02
2023
|
David Ashley Lee Executive VP, COO & CFO |
SELL
Open market or private sale
|
Direct |
1,401
-0.4%
|
$18,213
$13.41 P/Share
|
|
Mar 02
2023
|
Marshall S. Stanton SVP, Clinical & MD Affair |
SELL
Open market or private sale
|
Direct |
907
-1.71%
|
$11,791
$13.41 P/Share
|
|
Mar 02
2023
|
John E Davis Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
1,121
-0.86%
|
$14,573
$13.41 P/Share
|
|
Mar 02
2023
|
Jean F Holloway SVP, General Counsel |
SELL
Open market or private sale
|
Direct |
907
-0.67%
|
$11,791
$13.41 P/Share
|
|
Mar 01
2023
|
Dennis B Maier SVP, Operations |
BUY
Grant, award, or other acquisition
|
Direct |
3,663
+6.57%
|
-
|
|
Mar 01
2023
|
Rochelle L. Maney VP, Quality |
BUY
Grant, award, or other acquisition
|
Direct |
2,290
+7.02%
|
-
|
|
Mar 01
2023
|
Matthew A Getz VP, Human Resources |
BUY
Grant, award, or other acquisition
|
Direct |
2,290
+5.77%
|
-
|
|
Mar 01
2023
|
Amy Horton VP, Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,290
+2.07%
|
-
|
|
Mar 01
2023
|
Andrew M Green VP Regulatory |
BUY
Grant, award, or other acquisition
|
Direct |
2,290
+7.98%
|
-
|
|
Mar 01
2023
|
James P Mackin President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
21,818
+3.74%
|
-
|
|
Mar 01
2023
|
David Ashley Lee Executive VP, COO & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
4,579
+1.3%
|
-
|
|
Mar 01
2023
|
Marshall S. Stanton SVP, Clinical & MD Affair |
BUY
Grant, award, or other acquisition
|
Direct |
3,663
+6.47%
|
-
|
|
Mar 01
2023
|
John E Davis Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,663
+2.74%
|
-
|
|
Mar 01
2023
|
Jean F Holloway SVP, General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
3,663
+2.65%
|
-
|
|
Feb 28
2023
|
Rochelle L. Maney VP, Quality |
SELL
Open market or private sale
|
Direct |
406
-1.43%
|
$5,278
$13.24 P/Share
|
|
Feb 27
2023
|
David Ashley Lee Executive VP, COO & CFO |
SELL
Open market or private sale
|
Direct |
3,094
-0.45%
|
$37,128
$12.94 P/Share
|
|
Feb 27
2023
|
Amy Horton VP, Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
1,419
-0.68%
|
$17,028
$12.94 P/Share
|
|
Feb 27
2023
|
Jean F Holloway SVP, General Counsel |
SELL
Open market or private sale
|
Direct |
1,960
-0.76%
|
$23,520
$12.94 P/Share
|
|
Feb 27
2023
|
Rochelle L. Maney VP, Quality |
SELL
Grant, award, or other acquisition
|
Direct |
790
-2.7%
|
$9,480
$12.94 P/Share
|
|
Feb 27
2023
|
Rochelle L. Maney VP, Quality |
SELL
Open market or private sale
|
Direct |
878
-3.39%
|
$10,536
$12.94 P/Share
|
|
Feb 27
2023
|
John E Davis Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
2,393
-0.96%
|
$28,716
$12.94 P/Share
|
|
Feb 27
2023
|
James P Mackin President & CEO |
SELL
Open market or private sale
|
Direct |
22,630
-2.12%
|
$271,560
$12.94 P/Share
|
|
Feb 27
2023
|
Andrew M Green VP Regulatory |
SELL
Open market or private sale
|
Direct |
1,747
-3.81%
|
$20,964
$12.94 P/Share
|
|
Feb 27
2023
|
Dennis B Maier SVP, Operations |
SELL
Open market or private sale
|
Direct |
2,330
-2.51%
|
$27,960
$12.94 P/Share
|
|
Feb 27
2023
|
Marshall S. Stanton SVP, Clinical & MD Affair |
SELL
Open market or private sale
|
Direct |
2,337
-2.48%
|
$28,044
$12.94 P/Share
|
|
Feb 27
2023
|
Matthew A Getz VP, Human Resources |
SELL
Open market or private sale
|
Direct |
1,600
-2.36%
|
$19,200
$12.94 P/Share
|
|
Feb 23
2023
|
David Ashley Lee Executive VP, COO & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
14,835
+2.11%
|
-
|
|
Feb 23
2023
|
Amy Horton VP, Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,596
+3.02%
|
-
|
|
Feb 23
2023
|
Jean F Holloway SVP, General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
11,526
+4.24%
|
-
|
|
Feb 23
2023
|
Rochelle L. Maney VP, Quality |
BUY
Grant, award, or other acquisition
|
Direct |
6,596
+10.5%
|
-
|
|
Feb 23
2023
|
John E Davis Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
11,400
+4.34%
|
-
|
|
Feb 23
2023
|
James P Mackin President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
70,430
+6.14%
|
-
|
|
Feb 23
2023
|
Andrew M Green VP Regulatory |
BUY
Grant, award, or other acquisition
|
Direct |
7,018
+12.87%
|
-
|
|
Feb 23
2023
|
Dennis B Maier SVP, Operations |
BUY
Grant, award, or other acquisition
|
Direct |
10,088
+9.58%
|
-
|
|
Feb 23
2023
|
Marshall S. Stanton SVP, Clinical & MD Affair |
BUY
Grant, award, or other acquisition
|
Direct |
11,210
+10.35%
|
-
|
|
Feb 23
2023
|
Matthew A Getz VP, Human Resources |
BUY
Grant, award, or other acquisition
|
Direct |
6,596
+8.67%
|
-
|
|
Feb 19
2023
|
Matthew A Getz VP, Human Resources |
SELL
Payment of exercise price or tax liability
|
Direct |
1,407
-2.25%
|
$18,291
$13.96 P/Share
|
|
Feb 19
2023
|
Jean F Holloway SVP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
1,700
-0.69%
|
$22,100
$13.96 P/Share
|
|
Feb 19
2023
|
David Ashley Lee Executive VP, COO & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,630
-0.39%
|
$34,190
$13.96 P/Share
|
|
Feb 19
2023
|
Dennis B Maier SVP, Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
1,407
-1.68%
|
$18,291
$13.96 P/Share
|
|
Feb 19
2023
|
Amy Horton VP, Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,365
-0.67%
|
$17,745
$13.96 P/Share
|
|
Feb 19
2023
|
John E Davis Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,247
-0.94%
|
$29,211
$13.96 P/Share
|
|
Feb 19
2023
|
James P Mackin President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
10,692
-1.07%
|
$138,996
$13.96 P/Share
|
|
Feb 17
2023
|
Matthew A Getz VP, Human Resources |
SELL
Payment of exercise price or tax liability
|
Direct |
363
-1.14%
|
$4,719
$13.96 P/Share
|